TITLE:
Schizophrenia Study In Adults

CONDITION:
Schizophrenia

INTERVENTION:
talnetant

SUMMARY:

      A Placebo Controlled Study For Patients With Schizophrenia
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 65 Years
Criteria:

        Inclusion Criteria:

          -  Patient must meet diagnostic criteria for schizophrenia.

        Exclusion Criteria:

          -  Patients with other psychotic disorders.

          -  Patients whose condition is due to the direct physiological effects of a substances
             (e.g., drug abuse) or a general medical condition.

          -  Patients with a history of autistic disorder or another pervasive developmental
             disorder.

          -  Patients with epilepsy or a history of seizures requiring treatment.

          -  Patients who are excluded from taking the drug risperidone.

          -  Patients who pose a current serious suicidal or homicidal risk.

          -  Patients who are adequately stabilized on their treatment.
      
